Hong Kong has authorized the emergency use of BioNTech-Fosun Pharmaceutical's coronavirus vaccine BNT162b2. The first one million doses are currently being tested for safety and quality and are likely to be shipped from Germany to Hong Kong at the end of next month. In total, Hong Kong plans to purchase up to 7.5 million doses of the drug.
Hong Kong has authorized the emergency use of BioNTech-Fosun Pharmaceutical's coronavirus vaccine BNT162b2. The first one million doses are currently being tested for safety and quality and are likely to be shipped from Germany to Hong Kong at the end of next month. In total, Hong Kong plans to purchase up to 7.5 million doses of the drug. 
English (US) 